Browsing Tag
NASDAQ
800 posts
Starbucks weighs $3bn Japan stake sale as asset-light strategy expands
Starbucks may sell control of its Japan business for around $3 billion, testing whether an asset-light model can unlock value without sacrificing growth.
Why is Hafnia paying 46% more per share to increase its stake in TORM?
Hafnia is spending another $145.1 million to increase its ownership of TORM from 13.97% to approximately 18.22%. The investment gives Hafnia greater exposure to record tanker earnings and considerable strategic influence, while still leaving it well below Denmark’s mandatory takeover threshold.
Why Hub Group brought back its former CEO as costs rise and Nasdaq deadline expires
Hub Group, Inc. has returned David Yeager to the chief executive role and recruited former TreeHouse Foods finance chief Patrick O'Donnell as CFO-elect while a multiyear accounting restatement, potential Nasdaq delisting process and new cost-reduction programme reshape the logistics company.
The Trade Desk cuts 15% of workforce as Jeff Green gets stock option tied to $105 target
The Trade Desk is eliminating about 15% of its workforce and reorganising employees into smaller teams after revenue growth slowed sharply, while a new performance-based option could allow Chief Executive Officer Jeff Green to buy up to 7 million shares if the stock reaches targets extending to $105.
Vera Bradley stock surges as turnaround delivers profit, cash growth and stronger direct sales
Vera Bradley returned to profit as direct sales rose 8%, inventory fell 28% and cash doubled, sending shares sharply higher after earnings.
Algorhythm makes $23m AI power pivot with Azure Energy acquisition
Algorhythm buys Azure Energy for $23 million, pivoting toward AI data-center power as investors weigh $220 million of estimated project value.
More than half of Cambium Networks’ workforce is gone. Can the networking company survive the next phase?
Cambium Networks Corporation has eliminated 260 jobs, or 53.6% of its global workforce, while its principal UK operating subsidiary enters administration and administrators explore asset sales amid severe liquidity and debt pressure.
EverCommerce (NASDAQ: EVCM) lifts total buyback authorization to $325m after stock slide
EverCommerce has added $25 million to its existing share repurchase programme and extended it through 2027, a capital-allocation signal arriving after a sharp decline in the software company’s share price.
Eloxx Pharmaceuticals (NASDAQ: ELOX) starts 24-patient EXACT trial of exaluren
Eloxx Pharmaceuticals has dosed the first two patients in its 24-person Phase 2b EXACT study of exaluren, testing whether nonsense mutation readthrough can restore functional kidney protein in Alport syndrome.
Axogen (NASDAQ: AXGN) to buy BioCircuit for $200m and prices $208.7m offering
Axogen is acquiring BioCircuit Technologies for $200 million in cash while pricing a $208.7 million equity offering, adding the FDA-approved NerveTape platform to its peripheral nerve repair portfolio.